AFNET – the Atrial Fibrillation NETwork

Physicians and scientists co-operate within the AFNET. A network is formed by hospitals and doctors’ offices – reaching from GPs to university hospitals.

Atrial Fibrillation – Information for Patients

Atrial Fibrillation is the most common arrhythmia of the heart – especially in elderly people. We inform you about the current treatment options.

Research – Clinical Trials on a European Level

Several million people in Europe live with atrial fibrillation. We investigate new treatment options. Within AFNET trials scientists co-operate on a European level.

Results – for a better treatment

New findings from AFNET trials flow into the clinical routine. AFNET experts develop recommendations for the therapy of atrial fibrillation.




[14.11.2013 ] On 4th November 2013 the 1000th patient was enrolled in the... [read more]
[31.08.2013 ] In contrast, a CHA2DS2-VASc score of 0 identifies a... [read more]
[27.08.2013 ] The fourth AFNET/EHRA consensus conference was convened to... [read more]
[26.06.2013 ] The PREFER AF registry study, which provides a ‘snapshot’... [read more]
[25.06.2013 ] Using catheter ablation to create complete linear lesions... [read more]
[23.06.2013 ] The abstract study found that patients with paroxysmal AF,... [read more]
[13.11.2012 ] The German Competence Network on Atrial Fibrillation (AFNET... [read more]
[02.08.2011 ] Largest pan-European study to determine whether an early... [read more]